Table of Contents
Volume 3 | Supplement 1
Publication Date: March 2002- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Contributions | ||
S5-S9 |
Chemotherapy Regimens in Advanced NonSmall-Cell Lung Cancer: Recent Randomized Trials Chandra P. Belani |
|
S10-S16 |
Gemcitabine-Based Doublets for Advanced NonSmall-Cell Lung Cancer: Beyond Gemcitabine/ Cisplatin Ronald B. Natale |
|
S17-S21 |
Combined-Modality Therapy for Inoperable NonSmall-Cell Lung Cancer Using Gemcitabine Walter John Curran, Jr. |
|
S22-S25 |
Pemetrexed (Alimta®): A New Antifolate for NonSmall-Cell Lung Cancer David S. Ettinger |
|
S26-S29 |
The Evolving Role of Gemcitabine and Pemetrexed (Alimta®) in the Management of Patients with Malignant Mesothelioma Mark R. Green |
|
S30-S38 |
Targeted Therapy Using Novel Agents in the Treatment of NonSmall-Cell Lung Cancer Roy S. Herbst |